1. Determinants of disease acceptance in renal transplantation patients assessed with the application of Acceptance Illness Scale (AIS)
- Author
-
Anna Wiela-Hojeńska, Arkadiusz Adamiszak, Olga Fedorowicz, Ewa Jaźwińska-Tarnawska, Niewiński P, and Magdalena Krajewska
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,MEDLINE ,Pharmacist ,Pharmaceutical Science ,Disease ,RM1-950 ,Affect (psychology) ,Young Adult ,Pharmacotherapy ,Pharmacy and materia medica ,Surveys and Questionnaires ,medicine ,Humans ,Kidney transplantation ,Aged ,Aged, 80 and over ,Pharmacology ,business.industry ,Middle Aged ,medicine.disease ,Kidney Transplantation ,Clinical pharmacy ,Transplantation ,RS1-441 ,Emergency medicine ,Kidney Failure, Chronic ,Female ,Therapeutics. Pharmacology ,business ,Attitude to Health - Abstract
Purpose: Kidney transplant patients require long-term pharmacotherapy with a significant risk of drug-related complications. The disease acceptance may significantly affect the effectiveness, safety, and patient adherence to their treatment. The purpose of this study was to evaluate, for kidney transplantation patients, the essential determinants for better disease acceptance, and whether a clinical pharmacist may influence its degree. Methods: The study involved 201 renal graft patients aged 18-81 years. The diagnostic survey method with the questionnaire of the Acceptance Illness Scale (AIS) and authors' query was used to obtain sociodemographic and co-morbidities data, the number of medications taken, the therapy cost, a patient needs for more attention from medical staff, and their willingness to cooperate with a clinical pharmacist. Results: The largest group (55.2%) of patients demonstrated a high level of acceptance of their health. However, in every disease acceptance score range (low, medium, high), the score was statistically lower in patients over 50 years of age (c2=7.27, p=0.026), occupationally inactive (c2 =13.8, p
- Published
- 2021